Concepedia

Michael Salacz

MS

Statistics

Publications

14

Citations

1.8K

H-Index

14

Active since

2004

Affiliations

Henry Ford Health System(Current)

Medical University of South Carolina

University of California San Diego

University of California, Los Angeles

University of California, Irvine

Michael Salacz is an author at Henry Ford Health System specializing in medicine, oncology, and glioblastoma.

Publications per year

2004–2022

14

Publications

14

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

, , +17

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text

, , +17

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Burt Nabors, Karen Fink, Tom Mikkelsen et al. · Neuro-Oncology · 2015 · 235 citations · Full text

, , +17

Anti-GPVI–associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface

Brian Boylan, Hong Chen, Vipul Rathore et al. · Blood · 2004 · 149 citations · Full text

, , +14

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

Timothy F. Cloughesy, Kevin Petrecca, Tobias Walbert et al. · JAMA Oncology · 2020 · 140 citations · Full text

, , +14

1–5 of 14